{"hands_on_practices": [{"introduction": "Before a bacteriophage can be used in therapy or even in a controlled experiment, its concentration must be accurately determined. The plaque assay is the cornerstone technique for quantifying infectious phage particles. This exercise will guide you through the fundamental calculation used to determine the titer, or concentration, of a phage stock from the results of a standard dilution plating experiment, a skill essential for any work in virology [@problem_id:2084509].", "problem": "A research team in a microbiology laboratory is investigating a novel bacteriophage as a potential therapeutic agent against a multi-drug resistant strain of bacteria. To determine the concentration of infectious phage particles in their stock solution, they perform a plaque assay. The procedure involves creating a series of tenfold dilutions of the original phage stock. A volume of $100~\\mu\\text{L}$ is taken from the $10^{-6}$ dilution tube and is mixed with a culture of the host bacteria. This mixture is then spread evenly over the surface of an agar plate. After an appropriate incubation period, the researchers observe and count 55 distinct zones of clearing, known as plaques, on the bacterial lawn.\n\nAssuming each plaque originates from a single infectious phage particle, calculate the concentration of the original, undiluted phage stock. Express your answer in Plaque Forming Units per mL (PFU/mL). Your final answer must be written in scientific notation, rounded to two significant figures.", "solution": "We are asked to compute the concentration of infectious phage particles in the original stock, assuming each plaque arises from one infectious particle. The standard plaque assay relation between the original stock concentration $C_{0}$ (in PFU/mL), the observed plaque count $P$ (in PFU), the dilution factor $r$ (fraction of the original concentration), and the plated volume $V$ (in mL) is\n$$\nC_{0}=\\frac{P}{r\\,V}.\n$$\nHere, the given quantities are:\n- $P=55$ plaques,\n- $r=10^{-6}$ (a tenfold dilution to $10^{-6}$),\n- $V=100~\\mu\\text{L}=0.1~\\text{mL}=10^{-1}~\\text{mL}$.\n\nSubstituting,\n$$\nC_{0}=\\frac{55}{\\left(10^{-6}\\right)\\left(10^{-1}~\\text{mL}\\right)}=\\frac{55}{10^{-7}~\\text{mL}}=55\\times 10^{7}~\\text{PFU/mL}.\n$$\nWriting in standard scientific notation and rounding to two significant figures,\n$$\nC_{0}=5.5\\times 10^{8}~\\text{PFU/mL}.\n$$\nPer the instruction to report only the numerical value in the specified unit, the final numeric result is $5.5\\times 10^{8}$.", "answer": "$$\\boxed{5.5 \\times 10^{8}}$$", "id": "2084509"}, {"introduction": "The safety of a therapeutic phage is paramount. An ideal phage candidate for therapy must be strictly lytic, meaning it only kills bacteria, and must not carry any genes that could be harmful to the patient or promote antibiotic resistance. This practice simulates the critical bioinformatic safety screening process where a phage's genome is analyzed for such \"undesirable\" genes, providing a window into the modern genomic methods used to validate phage therapeutics before they reach the clinic [@problem_id:2084521].", "problem": "A biotechnology firm is developing a novel bacteriophage, designated `phiCure-1`, for therapeutic use against a multidrug-resistant strain of pathogenic *Escherichia coli*. As part of the pre-clinical safety assessment, the complete genome of `phiCure-1` was sequenced and annotated. To be considered for compassionate use, the phage must be strictly lytic and must not carry any genetic determinants that could inadvertently harm the patient or worsen the overall public health landscape.\n\nYour task is to analyze a subset of the annotated Open Reading Frames (ORFs) from the `phiCure-1` genome. An ORF is classified as \"undesirable\" if it meets one or more of the following criteria:\n1.  It encodes a protein whose primary function is to establish or maintain a lysogenic life cycle.\n2.  It encodes a protein that is a known toxin or a virulence factor that could increase the pathogenicity of the host bacterium.\n3.  It encodes a protein that confers resistance to any class of clinically used antibiotics.\n\nBased on the functional annotations provided below, identify all the ORFs from the list that should be classified as undesirable.\n\n**Annotated ORFs:**\nA. `ORF-101`: Annotation based on homology search: Terminase large subunit. Functionally associated with packaging the phage genome into capsids.\n\nB. `ORF-103`: Annotation based on homology search: Phage integrase, tyrosine recombinase family. Shows high sequence similarity to the `int` gene of bacteriophage lambda.\n\nC. `ORF-104`: Annotation based on homology search: Holin. Predicted to form pores in the host cell's inner membrane during the late stage of the lytic cycle.\n\nD. `ORF-105`: Annotation based on homology search: cI-like repressor. Contains a helix-turn-helix DNA-binding domain, homologous to transcriptional repressors that maintain lysogeny.\n\nE. `ORF-107`: Annotation based on homology search: Shiga-like toxin 1, subunit A. Homologous to the enzymatic subunit of a potent cytotoxin found in enterohemorrhagic *E. coli*.\n\nF. `ORF-108`: Annotation based on homology search: DNA Polymerase. A Pfu-like family B polymerase involved in DNA replication.\n\nG. `ORF-109`: Annotation based on homology search: Class A Beta-lactamase. Contains conserved motifs for hydrolyzing the amide bond in the beta-lactam ring of antibiotics like penicillin.\n\nSelect all options corresponding to the undesirable ORFs.", "solution": "Define the predicate $U(\\text{ORF})$ to denote that an ORF is undesirable. By the problem statement, $U(\\text{ORF})$ is true if and only if at least one of the following conditions holds:\n- $P_{1}$: The ORF encodes a protein establishing or maintaining lysogeny.\n- $P_{2}$: The ORF encodes a toxin or virulence factor.\n- $P_{3}$: The ORF encodes an antibiotic resistance determinant.\nFormally, $U(\\text{ORF})$ is true when $P_{1} \\lor P_{2} \\lor P_{3}$ is true.\n\nEvaluate each annotated ORF against $P_{1}$â€“$P_{3}$:\n- ORF-101 (Terminase large subunit): Packaging function in lytic cycle; not lysogeny, not toxin, not resistance. Thus $P_{1}=\\text{false}$, $P_{2}=\\text{false}$, $P_{3}=\\text{false}$, so $U(\\text{ORF-101})=\\text{false}$.\n- ORF-103 (Phage integrase, tyrosine recombinase): Mediates genome integration characteristic of lysogeny. Thus $P_{1}=\\text{true}$, so $U(\\text{ORF-103})=\\text{true}$.\n- ORF-104 (Holin): Lytic function enabling host lysis; not lysogeny, not toxin, not resistance. Thus $P_{1}=\\text{false}$, $P_{2}=\\text{false}$, $P_{3}=\\text{false}$, so $U(\\text{ORF-104})=\\text{false}$.\n- ORF-105 (cI-like repressor): Maintains lysogeny by repressing lytic genes. Thus $P_{1}=\\text{true}$, so $U(\\text{ORF-105})=\\text{true}$.\n- ORF-107 (Shiga-like toxin 1, subunit A): Known potent cytotoxin; increases pathogenicity. Thus $P_{2}=\\text{true}$, so $U(\\text{ORF-107})=\\text{true}$.\n- ORF-108 (DNA polymerase): Replication enzyme; not lysogeny, not toxin, not resistance. Thus $P_{1}=\\text{false}$, $P_{2}=\\text{false}$, $P_{3}=\\text{false}$, so $U(\\text{ORF-108})=\\text{false}$.\n- ORF-109 (Class A beta-lactamase): Confers resistance to beta-lactam antibiotics. Thus $P_{3}=\\text{true}$, so $U(\\text{ORF-109})=\\text{true}$.\n\nCollecting those with $U(\\text{ORF})=\\text{true}$ yields the undesirable set $\\{\\text{ORF-103},\\ \\text{ORF-105},\\ \\text{ORF-107},\\ \\text{ORF-109}\\}$, corresponding to options B, D, E, and G.", "answer": "$$\\boxed{BDEG}$$", "id": "2084521"}, {"introduction": "The evolution of bacterial resistance is a significant hurdle for the long-term success of phage therapy. However, resistance isn't always a free lunch for the bacterium; it can come with a fitness cost that makes the resistant strain less competitive in other ways. This thought experiment uses a mathematical model to explore such a trade-off, where bacteria gain phage resistance at the cost of motility, affecting their ability to reach a nutrient source. By analyzing this scenario, you'll develop a quantitative understanding of the co-evolutionary dynamics that can influence therapeutic outcomes [@problem_id:2084490].", "problem": "In a study of pathogen-phage coevolution, two strains of a bacterium are cultured in a liquid medium. The first strain, Strain S (Susceptible), is the wild-type, possessing a flagellum that enables motility. This flagellum also serves as the primary receptor for a lytic bacteriophage. The second strain, Strain R (Resistant), is a mutant that has lost its flagellum. Consequently, Strain R is non-motile but is completely resistant to infection by the phage.\n\nThe experiment is conducted in a long, thin tube. At time $t=0$, both strains are inoculated at one end of the tube ($x=0$), each with an initial population of $N_0$. A static, localized source of a limiting nutrient is located at a distance $L$ from the inoculation point. The nutrient concentration profile creates two distinct zones for bacterial growth:\n- For any position $x < L$, the nutrient level supports a specific growth rate of $\\mu_{min}$.\n- For any position $x \\ge L$, the nutrient level is richer and supports a specific growth rate of $\\mu_{max}$.\n\nThe motile Strain S exhibits positive chemotaxis, moving towards the nutrient source with an average net drift velocity of $v_d$. The non-motile Strain R remains localized at $x=0$. The lytic bacteriophage is distributed uniformly throughout the entire tube and causes lysis of the susceptible Strain S with a constant first-order rate constant $\\lambda$. Strain R is unaffected by the phage.\n\nAssuming the experiment runs for a total time $T$, which is greater than the time required for Strain S to reach the nutrient source (i.e., $T > L/v_d$), derive a symbolic expression for the ratio of the final population of the resistant strain to that of the susceptible strain, $N_R(T)/N_S(T)$.", "solution": "Let $t_{L}$ denote the time for Strain S to reach the nutrient source at $x=L$. By constant drift, $t_{L}=\\frac{L}{v_{d}}$. Because $T>t_{L}$, Strain S experiences two growth phases.\n\nStrain R remains at $x=0<L$, so its specific growth rate is $\\mu_{min}$ for all $t\\in[0,T]$, and it is unaffected by phage. Its population dynamics satisfy\n$$\n\\frac{dN_{R}}{dt}=\\mu_{min}N_{R},\\qquad N_{R}(0)=N_{0},\n$$\nwith solution\n$$\nN_{R}(T)=N_{0}\\exp\\!\\left(\\mu_{min}T\\right).\n$$\n\nStrain S is susceptible to phage lysis at first-order rate constant $\\lambda$ everywhere and has piecewise growth due to the nutrient profile. For $0\\le t\\le t_{L}$, it is in the region $x<L$ with specific growth $\\mu_{min}$, so the net specific rate is $\\mu_{min}-\\lambda$:\n$$\n\\frac{dN_{S}}{dt}=(\\mu_{min}-\\lambda)N_{S},\\qquad N_{S}(0)=N_{0},\n$$\ngiving\n$$\nN_{S}(t_{L})=N_{0}\\exp\\!\\left((\\mu_{min}-\\lambda)t_{L}\\right).\n$$\nFor $t_{L}< t\\le T$, it is in the region $x\\ge L$ with specific growth $\\mu_{max}$, so the net specific rate is $\\mu_{max}-\\lambda$:\n$$\n\\frac{dN_{S}}{dt}=(\\mu_{max}-\\lambda)N_{S},\\qquad N_{S}(t_{L})\\ \\text{as above},\n$$\nyielding\n$$\nN_{S}(T)=N_{S}(t_{L})\\exp\\!\\left((\\mu_{max}-\\lambda)(T-t_{L})\\right)\n= N_{0}\\exp\\!\\left((\\mu_{min}-\\lambda)t_{L}+(\\mu_{max}-\\lambda)(T-t_{L})\\right).\n$$\nSubstitute $t_{L}=\\frac{L}{v_{d}}$ and simplify the exponent:\n$$\nN_{S}(T)=N_{0}\\exp\\!\\left((\\mu_{max}-\\lambda)T+(\\mu_{min}-\\mu_{max})\\frac{L}{v_{d}}\\right).\n$$\n\nTherefore, the ratio is\n$$\n\\frac{N_{R}(T)}{N_{S}(T)}=\\frac{N_{0}\\exp\\!\\left(\\mu_{min}T\\right)}{N_{0}\\exp\\!\\left((\\mu_{max}-\\lambda)T+(\\mu_{min}-\\mu_{max})\\frac{L}{v_{d}}\\right)}\n=\\exp\\!\\left(\\mu_{min}T-(\\mu_{max}-\\lambda)T-(\\mu_{min}-\\mu_{max})\\frac{L}{v_{d}}\\right).\n$$\nRewriting,\n$$\n\\frac{N_{R}(T)}{N_{S}(T)}=\\exp\\!\\left(\\lambda T-(\\mu_{max}-\\mu_{min})\\left(T-\\frac{L}{v_{d}}\\right)\\right).\n$$", "answer": "$$\\boxed{\\exp\\!\\left(\\lambda T-(\\mu_{max}-\\mu_{min})\\left(T-\\frac{L}{v_{d}}\\right)\\right)}$$", "id": "2084490"}]}